MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas-Reference-Cited by-同舟云学术

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

Published:2013-06-28 Issue:12 Volume:26 Page:1632-1641
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ha Sang Y,Lee Jeeyun,Kang So Y,Do In-Gu,Ahn Soomin,Park Joon O,Kang Won K,Choi Min-Gew,Sohn Tae S,Bae Jae M,Kim Sung,Kim Minji,Kim Seonwoo,Park Cheol K,Ignatius Ou Sai-Hong,Kim Kyoung-Mee

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2013108.pdf

Reference33 articles.

1. Eder JP, Vande Woude GF, Boerner SA et al. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 2009;15:2207–2214.

2. Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687–697.

3. Graziano F, Galluccio N, Lorenzini P et al. Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer. J Clin Oncol 2011;29:4789–4795.

4. Yap TA, Olmos D, Brunetto AT et al. Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol 2011;29:1271–1279.

5. Park WS, Oh RR, Kim YS et al. Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS 2000;108:195–200.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer;2024-07-16

2. Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer;Health Science Reports;2024-07

3. Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer;Frontiers in Oncology;2024-06-14

4. Analysis of cuproptosis-related genes signature in prognosis and immune landscape in Head and neck squamous cell carcinoma;2024-05-08

5. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04